🚀 VC round data is live in beta, check it out!
Welby Valuation Multiples
Discover revenue and EBITDA valuation multiples for Welby and similar public comparables like Physitrack, MRSO, MedApp, Healixa and more.
Welby Overview
About Welby
Welby Inc offers patients and their families digital tools helping medical treatment and prevention of the progression of disease. The company co-develops and co-provides digital services with pharmaceuticals, medical device companies, governments, along with patients and healthcare professionals.
Founded
2011
HQ
Employees
48
Website
Financials (LTM)
EV
$17M
Welby Financials
Welby reported last 12-month revenue of $4M.
In the same LTM period, Welby generated had net loss of ($4M).
Revenue (LTM)
Welby P&L
In the most recent fiscal year, Welby reported revenue of $4M and EBITDA of ($3M).
Welby expects next 12-month revenue of XXX and NTM EBITDA of XXX
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Revenue | $4M | XXX | $4M | XXX | XXX | XXX |
| Gross Profit | — | XXX | $3M | XXX | XXX | XXX |
| Gross Margin | — | XXX | 68% | XXX | XXX | XXX |
| EBITDA | — | XXX | ($3M) | XXX | XXX | XXX |
| EBITDA Margin | — | XXX | (76%) | XXX | XXX | XXX |
| EBIT Margin | (71%) | XXX | (69%) | XXX | XXX | XXX |
| Net Profit | ($4M) | XXX | ($3M) | XXX | XXX | XXX |
| Net Margin | (85%) | XXX | (82%) | XXX | XXX | XXX |
Financial data powered by Morningstar, Inc.
Welby Stock Performance
Welby has current market cap of $17M, and enterprise value of $17M.
Market Cap Evolution
Welby's stock price is $2.09.
| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $17M | $17M | 0.3% | XXX | XXX | XXX | $-0.41 |
Benchmark Trading Valuation Multiples by Industry
Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.
Start Free TrialWelby Valuation Multiples
Welby trades at 4.0x EV/Revenue multiple, and (5.3x) EV/EBITDA.
EV / Revenue (LTM)
Welby Financial Valuation Multiples
As of April 20, 2026, Welby has market cap of $17M and EV of $17M.
Equity research analysts estimate Welby's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
Welby has a P/E ratio of (4.9x).
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Market cap (current) | $17M | XXX | $17M | XXX | XXX | XXX |
| EV (current) | $17M | XXX | $17M | XXX | XXX | XXX |
| EV/Revenue | 4.0x | XXX | 4.0x | XXX | XXX | XXX |
| EV/EBITDA | — | XXX | (5.3x) | XXX | XXX | XXX |
| EV/EBIT | (5.7x) | XXX | (5.8x) | XXX | XXX | XXX |
| EV/Gross Profit | — | XXX | 5.9x | XXX | XXX | XXX |
| P/E | (4.9x) | XXX | (5.1x) | XXX | XXX | XXX |
| EV/FCF | — | XXX | (6.1x) | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Verified Welby Valuation Multiples
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.
Welby Margins & Growth Rates
Welby's revenue in the last fiscal year grew by 20%.
Welby's revenue per employee in the last FY averaged $0.1M, while opex per employee averaged $0.1M for the same period.
Welby Operational Valuation Multiples
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Revenue Growth | — | XXX | 20% | XXX | XXX | XXX |
| EBITDA Margin | — | XXX | (76%) | XXX | XXX | XXX |
| EBITDA Growth | — | XXX | (37%) | XXX | XXX | XXX |
| Revenue per Employee | — | XXX | $0.1M | XXX | XXX | XXX |
| Opex per Employee | — | XXX | $0.1M | XXX | XXX | XXX |
| Opex to Revenue | — | XXX | 137% | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Welby Public Comps
See public comps and valuation multiples for other Digital Therapeutics and Healthcare Software comps.
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| LTM | 2026E | 2027E | LTM | 2026E | 2027E | |
| Welby | XXX | XXX | XXX | XXX | XXX | XXX |
| Physitrack | XXX | XXX | XXX | XXX | XXX | XXX |
| MRSO | XXX | XXX | XXX | XXX | XXX | XXX |
| MedApp | XXX | XXX | XXX | XXX | XXX | XXX |
| Healixa | XXX | XXX | XXX | XXX | XXX | XXX |
| EUDA Health | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc.
Welby M&A Activity
Welby acquired XXX companies to date.
Last acquisition by Welby was on XXXXXXXX, XXXXX. Welby acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX).
Latest Acquisitions by Welby
| Acquired Company | Valuation | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
Get Verified M&A Valuation Multiples
Sign up to see revenue and EBITDA valuation multiples for 150K+ M&A deals.
Start Free TrialWelby Investment Activity
Welby invested in XXX companies to date.
Welby made its latest investment on XXXXXXXX, XXXXX. Welby invested in XXXXXXXX for XXX (EV/Revenue multiple of XXX).
Latest Investments by Welby
| Company | Valuation | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples
Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.
Start Free TrialAbout Welby
| When was Welby founded? | Welby was founded in 2011. |
| Where is Welby headquartered? | Welby is headquartered in Japan. |
| How many employees does Welby have? | As of today, Welby has over 48 employees. |
| Is Welby publicly listed? | Yes, Welby is a public company listed on Tokyo Stock Exchange. |
| What is the stock symbol of Welby? | Welby trades under 4438 ticker. |
| When did Welby go public? | Welby went public in 2019. |
| Who are competitors of Welby? | Welby main competitors are Physitrack, MRSO, MedApp, Healixa. |
| What is the current market cap of Welby? | Welby's current market cap is $17M. |
| What is the current revenue of Welby? | Welby's last 12 months revenue is $4M. |
| What is the current EV/Revenue multiple of Welby? | Current revenue multiple of Welby is 4.0x. |
| Is Welby profitable? | No, Welby is not profitable. |
| What is the current net income of Welby? | Welby's last 12 months net income is ($4M). |
Start Your
Free Trial Today
Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.